Discontinued operations (including Specialty Chemicals)

Discontinued operations and held for sale

The results and cash flows from discontinued operations in 2018, as well as 2017, and the assets and liabilities held for sale at June 30, 2018, and December 31, 2017, almost completely relate to the Specialty Chemicals business.

The Specialty Chemicals business consists of the Specialty Chemicals Business Area and certain other assets and liabilities and income and expenses which are directly attributed to the Specialty Chemicals business from the Other activities. As from December 22, 2017, the Specialty Chemicals business is classified as held for sale and discontinued operations, therefore the consolidated statement of income for 2017 has been represented to show the results of the Specialty Chemicals business as discontinued operations.

Revenue

Revenue of discontinued operations consists of revenue of Specialty Chemicals and eliminations of intercompany revenue.

Adjusted operating income

In Q2 2018, adjusted operating income was up 50% at €252 million (2017: €168 million).

  • In Specialty Chemicals, adjusted operating income was higher, mainly due to stronger price/mix effects and productivity improvements, partly offset by the impact of adverse currencies, restructuring costs and other one-off costs
  • Held for sale effects/other mainly relates to the impact of ceasing depreciation and amortization, partly offset by the related impact on inventory valuation following IFRS 5 assets held for sale accounting. Total impact in Q2 2018 was €74 million.

Operating income

In Q2 2018, operating income was negatively impacted by identified items totaling €8 million relating to separation costs.

Summary of financial outcomes discontinued operations

Second quarter

 

January-June

2017 *

2018

∆%

in € millions

2017 *

2018

∆%

*

Represented to present the Specialty Chemicals business as discontinued operations

1,252

1,264

1

Revenue

2,536

2,510

(1)

168

252

50

Adjusted operating income

336

460

37

178

244

37

Operating income

346

438

27

13.4

19.9

 

ROS%

13.2

18.3

 

14.2

19.3

 

OPI margin%

13.6

17.5

 

 

 

 

 

 

 

 

 

 

 

Average invested capital

3,674

3,598

 

 

 

 

ROI%

15.6

20.7

 

 

 

 

 

 

 

 

89

98

 

Capital expenditures

164

161

 

114

166

 

Net cash from operating activities

205

246

 

 

 

 

 

 

 

 

134

165

 

Profit for the period

250

307

 

 

 

 

Number of employees

10,000

9,800

 

Profit and loss discontinued operations

Second quarter

 

January-June

2017 *

2018

in € millions

2017 *

2018

*

Represented to present the Specialty Chemicals business as discontinued operations

1,252

1,264

Revenues

2,536

2,510

(1,077)

(1,030)

Expenses

(2,196)

(2,087)

175

234

Profit before tax

340

423

(41)

(69)

Income tax

(90)

(116)

134

165

Profit for the period

250

307

Adjusted operating income of discontinued operations

Second quarter

 

January-June

2017 1

2018

∆%

in € millions

2017 1

2018

∆%

1

Represented to present the Specialty Chemicals business as discontinued operations

2

2017 figures include allocations from Other activities

166

175

5

Specialty Chemicals 2

332

325

(2)

2

77

 

Held for sale effects/other

4

135

 

168

252

50

Total

336

460

37

Operating income of discontinued operations

Second quarter

 

January-June

2017 1

2018

∆%

in € millions

2017 1

2018

∆%

1

Represented to present the Specialty Chemicals business as discontinued operations

2

2017 figures include allocations from Other activities

184

175

(5)

Specialty Chemicals 2

350

325

(7)

(6)

69

 

Held for sale effects/other

(4)

113

 

178

244

37

Total

346

438

27

Assets and liabilities held for sale

in € millions

December 31, 2017

June 30, 2018

Intangible assets

787

793

Property, plant and equipment

2,266

2,391

Financial non-current assets

205

215

Inventories

503

519

Receivables

840

990

Assets held for sale

4,601

4,908

Non-current liabilities

765

775

Short-term borrowings

341

266

Current payables

1,090

1,091

Liabilities held for sale

2,196

2,132

Cash flows from discontinued operations

Second quarter

 

January-June

2017

2018

in € millions

2017

2018

114

166

Net cash from operating activities

205

248

(83)

(100)

Net cash from investing activities

(161)

(160)

(3)

(66)

Net cash from financing activities

(6)

(88)

28

Cash flows from discontinued operations

38